This analysis indicated that LPAR1 was highly expressed in lymphoma and lowly expressed in prostate cancer, bladder cancer, brain and central nervous system cancer, head and neck cancer, colorectal cancer, kidney cancer, lung cancer, leukemia, melanoma, and ovarian cancer (Figure 1A). Here, LPAR1 is linked to prostate cancer.